Alzheimer's Disease Research: What Has Guided Research So Far and Why It Is High Time for a Paradigm Shift

被引：0
|
作者：
Perry, George [1 ]
Castellani, Rudolph [2 ]
机构：
[1] Univ Texas San Antonio, San Antonio, TX 78249 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
来源：
JOURNAL OF ALZHEIMERS DISEASE | 2024年 / 100卷 / 02期
关键词：
D O I：
10.3233/JAD-249012
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：735 / 735
页数：1
相关论文
共 50 条
  • [21] Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?
    Doig, Andrew J.
    del Castillo-Frias, Maria P.
    Berthoumieu, Olivia
    Tarus, Bogdan
    Nasica-Labouze, Jessica
    Sterpone, Fabio
    Nguyen, Phuong H.
    Hooper, Nigel M.
    Faller, Peter
    Derreumaux, Philippe
    ACS CHEMICAL NEUROSCIENCE, 2017, 8 (07): : 1435 - 1437
  • [22] PARADIGM FOR FUTURE-RESEARCH IN STRESS AND DISEASE - RECENT KNOWLEDGE OF AFFERENT CEREBRAL CIRCUITS HAS FORCED A PARADIGM SHIFT THAT RECONCILES DIVERSE VIEWS OF STRESS AND DISEASE
    WOLF, S
    HOMEOSTASIS IN HEALTH AND DISEASE, 1994, 35 (1-2): : 20 - 23
  • [23] Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?
    Marchetti, Cristina
    Marie, Helene
    REVIEWS IN THE NEUROSCIENCES, 2011, 22 (04) : 373 - 402
  • [24] WHAT GOOD ARE DIGITAL TECHNOLOGIES IN ALZHEIMER'S DISEASE RESEARCH? - A SYSTEMATIC LITERATURE REVIEW
    Vinals, L.
    Akinola, T.
    Sarri, G.
    VALUE IN HEALTH, 2019, 22 : S754 - S754
  • [25] Understanding what factors facilitate and impede Alzheimer's disease caregiver research participation
    Tarlow, B
    Mahoney, D
    GERONTOLOGIST, 2002, 42 : 75 - 75
  • [26] Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know
    Erickson, Claire M.
    Chin, Nathaniel A.
    Johnson, Sterling C.
    Gleason, Carey E.
    Clark, Lindsay R.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2021, 13 (01)
  • [27] Alzheimer research forum live discussion: Brain derived neurotrophic factor and Alzheimer's disease - What is the connection?
    Berchtold, NC
    Cotman, CW
    Strobel, G
    Xiao, QR
    Trakya, FK
    Pochet, R
    Lessmann, V
    Wang, DL
    Holcomb, L
    Falmestock, M
    Duong, TH
    Busciglio, J
    Zhu, SW
    JOURNAL OF ALZHEIMERS DISEASE, 2005, 7 (02) : 173 - 180
  • [28] Clinical Observational Research on Alzheimer's Disease: What Clinical Trial Registries Can Tell
    Dal-Re, Rafael
    Fauria, Karine
    Gramunt, Nina
    Luis Molinuevo, Jose
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (01) : 183 - 190
  • [29] WHAT IS THE INFLUENCE ON CLINICAL RESEARCH OF THE EMA GUIDELINE ON MEDICINAL PRODUCTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE?
    Caron, M.
    Acquadro, C.
    Emery, M. P.
    VALUE IN HEALTH, 2012, 15 (04) : A148 - A148
  • [30] What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?
    Wallin, Anders
    Alladi, Suvarna
    Black, Sandra E.
    Chen, Christopher
    Greenberg, Steven M.
    Gustafson, Deborah
    Isaacs, Jeremy D.
    Jokinen, Hanna
    Kalaria, Raj
    Mok, Vincent
    Pantoni, Leonardo
    Pasquier, Florence
    Roman, Gustavo C.
    Rosenberg, Gary A.
    Schmidt, Reinhold
    Smith, Eric E.
    Hainsworth, Atticus H.
    CEREBRAL CIRCULATION - COGNITION AND BEHAVIOR, 2022, 3
12345